Roche reports strong sales growth in the first nine months of 2017

Group sales rose 5% to CHF 39.4 billion. Sales in the Pharmaceuticals Division increased 5% to CHF 30.6 billion.

Source: Roche Investor Update - October 19, 2017 Category: Pharmaceuticals Source Type: news